Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 0.0495M
December 31, 2025 -0.0963M
September 30, 2025 -0.3018M
June 30, 2025 -0.0836M
March 31, 2025 -0.0898M
December 31, 2024 -0.032M
September 30, 2024 -0.0281M
June 30, 2024 -0.0118M
March 31, 2024 -0.1113M
December 31, 2023 -0.1273M
September 30, 2023 -0.0435M
June 30, 2023 -0.0001M
March 31, 2023 -0.0148M
December 31, 2022 -0.0085M
September 30, 2022 -0.0292M
June 30, 2022 0.0966M
March 31, 2022 -0.2112M
December 31, 2021 -0.2628M
September 30, 2021 -0.0304M
June 30, 2021 -0.0329M
March 31, 2021 -0.1971M
December 31, 2020 -0.0184M
September 30, 2020 -0.0406M
June 30, 2020 -0.0175M
March 31, 2020 -0.0859M
Date Value
December 31, 2019 -0.0283M
September 30, 2019 -1.472M
June 30, 2019 0.074M
March 31, 2019 -0.0381M
December 31, 2018 -0.0334M
September 30, 2018 -0.0428M
June 30, 2018 -0.0044M
March 31, 2018 0.00
December 31, 2017 -0.0172M
September 30, 2017 0.00
June 30, 2017 -0.0014M
March 31, 2017 -0.0019M
December 31, 2016 -0.0267M
September 30, 2016 -0.0035M
June 30, 2016 0.0059M
March 31, 2016 0.0069M
December 31, 2015 0.0155M
September 30, 2015 -0.0042M
June 30, 2015 0.0067M
March 31, 2015 -0.0033M
December 31, 2014 -0.0324M
September 30, 2014 -0.0173M
June 30, 2014 0.0047M
March 31, 2014 0.0065M
December 31, 2013 0.0011M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
RxSight, Inc. 4.652M
Abbott Laboratories -673.00M
Align Technology, Inc. -82.16M
AngioDynamics, Inc. -1.27M
Accuray, Inc. -1.353M